How much is Om Therapeutics worth in 2026?

Om Therapeutics has a current valuation of N/A based on their Seed Round round and secondary market data.

How much funding has Om Therapeutics raised?

Om Therapeutics has raised N/A in total funding across 1 funding rounds.

Om Therapeutics

Biotechnology

Om Therapeutics valuation and funding history | Last updated: March 22, 2024 | 1 funding rounds

Current Valuation

N/A

As of March 22, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Seed Round

Amount undisclosed

Last Funding

Mar 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
March 22, 2024	Seed Round	Undisclosed	N/A	-

Valuation Analysis

Current Valuation Metrics

Om Therapeutics is currently valued at N/A as of March 22, 2024.

Track Om Therapeutics Valuation Updates

Get notified when Om Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Om Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Om Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Om Therapeutics Worth in 2026?

Om Therapeutics is a leading private company in the Biotechnology sector. Track Om Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Om Therapeutics Valuation is Determined

Private company valuations like Om Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.